Sunitinib, Pemetrexed
A6181165
Phase 1 small_molecule completed
Quick answer
Sunitinib, Pemetrexed for Neoplasm, Malignant is a Phase 1 program (small_molecule) at Pfizer with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Pfizer
- Indication
- Neoplasm, Malignant
- Phase
- Phase 1
- Modality
- small_molecule
- Status
- completed